KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 83 filers reported holding KEZAR LIFE SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $45,000 | -59.5% | 18,200 | +15.3% | 0.00% | – |
| Q4 2022 | $111,000 | -33.5% | 15,788 | -18.5% | 0.00% | -100.0% |
| Q3 2022 | $167,000 | +827.8% | 19,371 | +340.2% | 0.00% | – |
| Q4 2019 | $18,000 | +28.6% | 4,400 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |